Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanguine Biosciences
Woburn, Massachusetts, United Statessanguinebio.com ↗
- Ownership
- Private
- Employees
- ~98
- Development stage
- Commercial
01
Overview
Sanguine Biosciences accelerates translational biomedical research by providing ethically sourced human biospecimens with rich clinical annotation to researchers worldwide. Their direct-to-donor model enables access to rare patient populations and complex study designs. They have supported over 2,000 studies for more than 100 diagnosed conditions with high delivery reliability.
- Therapeutic areas
- CardiovascularOncologyMetabolic DisordersImmunologyHematologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Cell therapyGene therapy
- Industry
- Drug Discovery Services
02
Partnerships
Supported translational and clinical research at 20 of the top 40 global pharmaceutical and biotechnology companiesHepatitis B Foundation
Beyond the preview
Go deeper on Sanguine Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanguine Biosciences.